Table 1.
Baseline demographics of the study population and their comparison based on the affected arterial territory.
| Variables | All Cases (N = 54) |
Arterial Territory | p-Value | |||
|---|---|---|---|---|---|---|
| ICA (N = 8) |
M1 (N = 26) |
Proximal M2 (N = 20) |
||||
| Age (years) | 67.9 ± 13.6 | 74.4 ± 15.7 | 64.7 ± 14.0 | 69.4 ± 11.5 | 0.175 | |
|
Male Sex
(n%) |
28 (51.9%) | 3 (37.5%) | 14 (53.8%) | 11 (55.0%) | 0.811 | |
|
Race
(n%) |
White/Caucasian | 23 (42.6%) | 3 (37.5%) | 9 (34.6%) | 11 (55.0%) | 0.577 |
| AfricanAmerican/Black | 30 (55.6%) | 5 (62.5%) | 16 (61.5%) | 9 (45.0%) | ||
| Asian | 1 (1.9%) | 0 (0.0%) | 1 (3.8%) | 0 (0.0%) | ||
| BMI (kg/m2) | 28.9 ± 9.7 | 33.2 ± 9.7 | 28.3 ± 11.2 | 27.9 ± 7.4 | 0.399 | |
| BMI grade | <30.0 | 36 (66.7%) | 5 (62.5%) | 19 (73.1%) | 12 (60.0%) | 0.624 |
| ≥30.0 | 18 (33.3%) | 3 (37.5%) | 7 (26.9%) | 8 (40.0%) | ||
| Hemoglobin level (gm/dL) | 12.4 ± 2.1 | 11.9 ± 3.0 | 11.9 ± 2.0 | 13.3 ± 1.4 | 0.061 | |
| Hematocrit (%) | 38.5 ± 5.7 | 36.4 ± 8.1 | 37.0 ± 5.2 | 41.3 ± 4.4 | 0.019 * p1: 0.799 p2: 0.047 p3: 0.005 * |
|
| WBC count (×103/mL) | 8.7 ± 3.0 | 8.9 ± 2.4 | 8.6 ± 3.0 | 8.7 ± 3.3 | 0.971 | |
| Platelet count (×103/mL) | 237.3 ± 79.3 | 223.9 ± 56.0 | 233.7 ± 70.5 | 247.4 ± 98.1 | 0.746 | |
| Platelet/WBC ratio | 29.2 ± 11.3 | 26.6 ± 8.7 | 29.1 ± 8.8 | 30.3 ± 15.0 | 0.740 | |
| Sodium level (mEq/L) | 139.2 ± 3.2 | 141.0 ± 4.2 | 138.3 ± 2.7 | 139.7 ± 3.1 | 0.085 | |
| Potassium level (mmol/L) | 4.1 ± 0.5 | 4.1 ± 0.4 | 4.1 ± 0.6 | 4.1 ± 0.4 | 0.964 | |
| Calcium level (mg/dL) | 8.8 ± 0.5 | 8.7 ± 0.5 | 8.9 ± 0.6 | 8.8 ± 0.5 | 0.725 | |
| Blood Glucose level (mg/dL) | 135.8 ± 65.1 | 118.3 ± 10.6 | 130.4 ± 73.6 | 149.8 ± 65.5 | 0.439 | |
| BUN/ creatinine ratio | 18.2 ± 7.8 | 17.5 ± 7.6 | 19.8 ± 8.5 | 16.5 ± 6.8 | 0.345 | |
| SBP (mmHg) | 148.2 ± 23.7 | 154.4 ± 21.2 | 144.2 ± 21.6 | 150.9 ± 27.3 | 0.468 | |
| DBP (mmHg) | 82.8 ± 19.9 | 88.0 ± 23.2 | 78.4 ± 18.6 | 86.4 ± 20.0 | 0.301 | |
| HR (beat/minute) | 80.6 ± 17.8 | 83.3 ± 20.8 | 80.9 ± 17.9 | 79.2 ± 17.2 | 0.857 | |
| RR (cycle/minute) | 17.6 ± 3.8 | 17.5 ± 4.3 | 17.6 ± 3.4 | 17.6 ± 4.3 | 0.997 | |
| SpO2 (%) | 97.9 ± 2.6 | 96.6 ± 4.1 | 98.1 ± 2.2 | 98.2 ± 2.4 | 0.329 | |
| NIHSS score | 15.0 ± 7.3 | 17.8 ± 5.7 | 15.5 ± 7.2 | 13.2 ± 7.9 | 0.307 | |
|
Left side improvement
(n%) |
32 (59.3%) | 4 (50.0%) | 16 (61.5%) | 12 (60.0%) | 0.866 | |
| HI | 0.3 ± 0.2 | 0.3 ± 0.2 | 0.3 ± 0.2 | 0.3 ± 0.2 | 0.990 | |
| Collaterals (n%) | Good | 26 (48.1%) | 4 (50.0%) | 13 (50.0%) | 9 (45.0%) | 0.933 |
| Poor | 28 (51.9%) | 4 (50.0%) | 13 (50.0%) | 11 (55.0%) | ||
| Hemorrhagic transformation (HT) within 48 H after MT, (n%) | 18 (33.3%) | 5 (62.5%) | 10 (38.5%) | 3 (15.0%) | 0.041 * p1: 0.231 p2: 0.012 * p3: 0.080 |
|
* Statistically significant (<0.05), p1 is ICA vs. M1, p2 is ICA vs. M2, p3 is M1 vs. M2.